-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Coya Therapeutics, Inc. quarterly and annual Income Tax Expense (Benefit) history and change rate from 2022 to Q2 2025.
- Coya Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Jun 2025 was $0.
- Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $-720,287, a 200% decline from 2023.
- Coya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $723,852.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)